PRESS RELEASES

• Press Release

  May 01, 2023

  Precision NanoSystems Joins Aldevron and Cytiva for expansion of mRNA Production Capability

  Fargo, North Dakota and Vancouver, British Columbia/PR/Newswire/May 1, 2023 -- Aldevron, a leading global manufacturer of DNA, RNA and proteins used in cell and gene therapies and vaccine development, will expand its mRNA production capabilities to include lipid nanoparticle (LNP...

  Read More

• Press Release

  Jul 26, 2022

  Precision NanoSystems and Replicate Bioscience in licensing deal to scale up genomic medicines

  SAN DIEGO, Calif., and Vancouver, British Columbia/PR Newswire/July 26, 2022 --In a move that signifies the heightened focus on mRNA as a key tool in human health, Precision NanoSystems (PNI) and Replicate Bioscience will enter a licensing agreement to accelerate the creation, sc...

  Read More

• Press Release

  Jun 13, 2022

  Precision NanoSystems and Aurora Vaccines join forces to accelerate the development of vaccine candidate for Hepatitis C virus

  Global leader in non-viral delivery of genomic medicines, Precision NanoSystems (PNI), entered into a strategic collaboration agreement with Aurora Vaccines to accelerate the development and manufacture of its Hepatitis C vaccine candidate. PNI will share its expertise in the dev...

  Read More

• Press Release

  May 09, 2022

  Precision NanoSystems Launches a Novel Lipid Nanoparticle Reagent to Scale Up Delivery of RNA into T Cells for Gene-Modified Cell Therapies

  Vancouver, British Columbia, May 9, 2022 – Precision NanoSystems has launched a new off-the-shelf lipid nanoparticle (LNP) reagent mix called Read More

• Press Release

  Aug 11, 2021

  Precision NanoSystems sets time and place to open new Genetic Medicine GMP Biomanufacturing Centre in Vancouver, BC

  Vancouver, British Columbia – August 11, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction. Slate...

  Read More

• Press Release

  Apr 20, 2021

  Precision NanoSystems Announces New Cell Therapy Reagent for Lipid Nanoparticle-based mRNA Delivery to T Cells

  Cell therapy Nucleic Acid Lipid Nanoparticles mRNA

  Vancouver, BC, Apr 20, 2021 - Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, today launched the GenVoy-ILM™ T Cell Kit for mRNA to enable lipid nanoparticle (LNP)-based ex vivo gene transfer. ...

  Read More